Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms

Heidrun Karlic, Alfred Lohninger, Supplementation of l-carnitine in athletes: does it make sense?, Nutrition, Volume 20, Issues 78, 2004, Pages 709-715, ISSN 0899-9007, 6
Zinc Citrate This type is easier on the stomach than other forms and absorbs well in the intestines
Wegovy (semaglutide) is a prescription injectable medication that helps with long-term weight management